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Streptococcus pneumoniae can cause disease in various human
tissues and organs, including the ear, the brain, the blood, and
the lung, and thus in highly diverse and dynamic environments.
It is challenging to study how pneumococci control virulence factor
expression, because cues of natural environments and the presence
of an immune system are difficult to simulate in vitro. Here, we apply
synthetic biology methods to reverse-engineer gene expression con-
trol in S. pneumoniae. A selection platform is described that allows
for straightforward identification of transcriptional regulatory elements
out of combinatorial libraries. We present TetR- and LacI-regulated pro-
moters that showexpression ranges of four orders ofmagnitude. Based
on these promoters, regulatory networks of higher complexity are
assembled, such as logic AND gates and IMPLY gates. We demon-
strate single-copy genome-integrated toggle switches that give
rise to bimodal population distributions. The tools described here
can be used to mimic complex expression patterns, such as the ones
found for pneumococcal virulence factors. Indeed, we were able to
rewire gene expression of the capsule operon, the main pneumococcal
virulence factor, to be externally inducible (YES gate) or to act as an
IMPLY gate (only expressed in absence of inducer). Importantly,
we demonstrate that these synthetic gene-regulatory networks
are functional in an influenza A virus superinfection murine model
of pneumonia, paving the way for in vivo investigations of the
importance of gene expression control on the pathogenicity of
S. pneumoniae.
Pneumococcus | toggle switch | synthetic biology | superinfection |
counterselection
Human pathogens and commensals reside in highly dynamicenvironments where they interact with host tissue, the im-
mune system, and niche competitors. Streptococcus pneumoniae
(pneumococcus) is a prominent example of a colonizer of such
complex habitats. Pneumococcus is generally found in a com-
mensal state in the human nasopharynx; however, pneumococci
can also cause disease, such as otitis media, meningitis, sepsis,
and pneumonia, and they are responsible for more than one
million deaths per year (1, 2). To date, it remains unclear how
pneumococcus switches from benign to pathogenic, and which
genes are exactly involved (3, 4).
Although many studies have been dedicated to unravel key
regulators and their regulons (5–11), how pneumococci accu-
rately control virulence gene expression under changing condi-
tions is poorly understood. One strategy to investigate complex
gene regulation relies on the approach of examining artificial
regulatory networks that mimic natural networks (12). Such ap-
proaches have yielded valuable insights on the mode of action of
complex gene-regulatory networks in model organisms such as
Escherichia coli and Bacillus subtilis (13–18), but for many human
pathogens these tools mostly still need to be developed.
Here, we apply synthetic biology approaches to engineer gene-
regulatory pathways in S. pneumoniae. A selection platform was
created to enable the identification of genetic elements for
specific gene expression patterns. Orthogonal transcription fac-
tors were introduced and functionalized in S. pneumoniae. Based
on these regulators, complex gene expression networks were
assembled and characterized, such as inverters, a logic AND and
IMPLY gate, and toggle switches. Using the here-described
tools, we rewired gene expression of the operon responsible
for the main pneumococcal virulence factor, the exopoly-
saccharide capsule. Importantly, we show that these synthetic
gene-regulatory networks can be induced in vivo and are functional
to control pneumococcal pathogenicity in an influenza-
superinfection model of pneumonia. This work now sets the
scene for further in vivo investigations of the contribution of gene
expression control on the pathogenicity of S. pneumoniae.
Results
Selection and Counterselection Systems for S. pneumoniae. Synthetic
gene-regulatory networks are difficult to construct to date in
S. pneumoniae, or even in model organisms, because of a lack of
well-characterized individual parts, and because of limited
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knowledge in predicting interference between assembled parts
(19–21). To bypass these limitations, we aimed at developing an
alternative strategy: the identification of regulatory elements based
on selection and counterselection of genetic libraries. Parts of de-
sired functionality, such as strong promoters, can be identified via
selection, by cloning promoter libraries in front of antibiotic resis-
tance markers (22). Conversely, weak promoters can be identified
via counterselection (23), and more complex transcription patterns
can be found via sequential selection and counterselection.
In order to create a positive selection platform for S. pneumoniae,
we first tested and cloned a set of five antibiotic resistance
markers under the control of the Zn2+-inducible promoter PZ1
(Fig. 1A) (24). As expected, cells only grew at high concentrations
of antibiotics when PZ1 was induced with high concentrations of
Zn2+. A large difference in dynamic response rate was observed
between different resistance markers (Fig. 1B). Pneumococci
responded to concentrations of chloramphenicol and tetracycline
within one order of magnitude of Zn2+ induction, kanamycin
spanned two orders of magnitude, and both erythromycin and
trimethoprim showed a response range of more than three orders
of magnitude (Fig. 1B). Since trimethoprim selection worked less
well on plates and is furthermore prone to lead to emergence
of spontaneously resistant cells (by single-nucleotide poly-
morphisms in dhfR), we chose erythromycin and its marker
erm as positive selector.
To date, and to our knowledge, there is only one counter-
selection system described for S. pneumoniae called Janus (25).
Janus cloning relies on a streptomycin-resistant strain that
becomes susceptible when the wild-type allele of the ribosomal
gene rpsL is expressed. Janus was furthermore extended by adding
the B. subtilis gene sacB (Sweet Janus) (26), which confers sucrose
sensitivity via an unknown mechanism (27); however, counter-
selection with sacB was never shown to work independently of the
Janus context in S. pneumoniae (26). The disadvantage of Janus
cloning is the requirement of a genetic background that carries a
mutated rpsL allele. The pheS counterselection system of E. coli
does not rely on a mutated genetic background (28). Expression of
the mutated phenylalanine-tRNA ligase PheSA294G allows for the
incorporation of a toxic analog of phenylalanine, called para-
chlorophenylalanine (PCPA), into proteins, which in turn causes
growth retardation. We introduced this system into S. pneumoniae
by expressing the pneumococcal equivalent of E. coli PheSA294G,
S. pneumoniae PheSA315G, under control of PZ1 (Fig. 1A), and
furthermore under control of a strong constitutive promoter. In the
presence of PCPA, the expression of PheSA315G indeed led to re-
duced growth, both in liquid culture (Fig. 1B) and on agar plates (SI
Appendix, Fig. S1 and Methods).
After the identification of a suitable selection system (erm/
erythromycin) and a counterselection system (pheS/PCPA) we
combined the two markers, together with luc (firefly luciferase),
allowing for the analysis of gene expression at the population
level, and with gfp (green fluorescent protein), allowing for
single-cell analysis. BglBrick cloning was used to assemble genes
in a consecutive manner into the vector pPEP (24) (Methods).
The resulting plasmid, named pPEP7, was first tested by placing
the polycistronic expression cassette under control of the Zn2+-
inducible promoter PZ1. Plasmid pPEP7PZ1 (harboring PZ1-
pheS-erm-luc-gfp) was transformed into S. pneumoniae D39V
(29), resulting in strain D-PEP7PZ1. As shown in Fig. 1C, when
strain D-PEP7PZ1 was grown in the presence of 0.1 μg·mL−1
erythromycin, a clear Zn2+-dependent growth profile was ob-
served. In contrast, when D-PEP7PZ1 was grown in the presence
of 2 mg·mL−1 PCPA, the dose–response relationship of Zn2+
induction was inverse; the absence of Zn2+ allowed for unin-
hibited growth, while high Zn2+ levels resulted in growth arrest
(Fig. 1D). However, after a lag period of ∼6 h, Zn2+-induced
cells restarted to grow (Fig. 1D), suggesting the rapid emergence
of mutants.
Efficient Selection of a Wide Range of Constitutive Synthetic
Promoters. We tested the ability of the new selection platform
to identify genetic elements of desired function by screening
promoter libraries. We used the strong synthetic promoter P2
(24) as a template for four distinct promoter libraries, containing
randomized sequences in the following: 1) the UP element [UP,
position −58 to −36 relative to the transcription start site (30),
resulting in 423 = 7.0 × 1013 potential combinations]; 2) the core
region [CORE, the 17 nucleotides between the −35 and the −10
hexamers, 417 = 1.7 × 1010 potential combinations]; 3) the −35
and −10 hexamers [TATA, only specific sequence variations were
Fig. 1. Selection marker characterization. (A) Sche-
matic representation of five selectable and one coun-
terselectable marker, including a description of their
enzymatic activities, integrated into the S. pneumoniae
D39V genome at the amiF (CEP) locus under the control
of the Zn2+-inducible promoter PZ1; CHL, chloram-
phenicol; ERY, erythromycin; KAN, kanamycin; PCPA,
para-chlorophenylalanine; TET, tetracycline; TMP, tri-
methoprim. (B) Determination of the maximum con-
centration allowing for outgrowth (starting from OD595
0.002, reaching OD595 0.2 or higher, within 10 h for
antibiotics, and within 5 h for PCPA) of strains harboring
selection and counterselection marker constructs, in
dependency of Zn2+ induction; cultures were tested in
duplicate with concentration series that doubled the
applied dosage in each consecutive step (one order of
magnitude was split into three steps of similar size: 1, 2,
5, and 10); in the case of PCPA, the upper limit of 2
mg·mL−1 was the highest concentration tested because
of solubility limitations. Average values of two bio-
logical replicates are shown. (C and D) Plate reader
assay sets in duplicate measuring cell density (OD595)
of S. pneumoniae D-PEP7PZ1 (see scheme; gfp, green
fluorescent protein; luc, luciferase) growing at different
induction levels of PZ1, in the presence of 0.1 μg·mL−1
ERY (C), or in the presence of 2 mg·mL−1 PCPA (D).
Every experiment was performed at least three
times, and representative data are shown.






























allowed (31), resulting in 26 = 64 potential combinations]; 4) the
proximal region [PROX, in this case the 14 nucleotides immediately
downstream of the −10 hexamer, 414 = 2.7 × 108 potential
combinations] (Fig. 2A).
Promoter libraries were constructed by extension of two oli-
gonucleotides that overlapped ∼20 bp, with one oligonucleotide
containing a randomized section (Fig. 2 A and B). Double-stranded
promoter constructs were integrated into pPEP7 via BglBrick as-
sembly and subcloned in E. coli MC1061. Approximately 3,500
colonies were pooled per library, and plasmid DNA was isolated,
cut with BglII to eliminate self-ligations (in this case, the restriction
site disappeared upon promoter integration), and the resulting four
pPEP7 libraries were transformed into S. pneumoniae D39V (Fig.
2B and Methods).
D39V libraries underwent four different selection treatments
(Fig. 2C). Cells were plated either with spectinomycin (resistance
marker of the pPEP backbone) to obtain all possible promoters
(control), or with a high concentration of erythromycin to obtain
strong promoters (positive selection). Alternatively, transformed
cultures were first treated with PCPA for 4 h (and additional
spectinomycin to inhibit nontransformed cells) and subsequently
plated either with a low dosage of erythromycin for intermediate
Fig. 2. Construction and selection of promoter li-
braries. (A) Sequence of the strong constitutive
promoter P2 and of four corresponding promoter
libraries harboring randomized sections; DIST, distal
region; UP, UP element; −35, −35 hexamer; CORE,
core region; −10, −10 hexamer; PROX, proximal re-
gion; transcription start sites are shown in bold, re-
striction sites are shown in dark gray, randomized
sequences are underlined; n = A/C/G/T, M = A/C, R =
A/G, W = A/T. (B) Workflow of the promoter library
construction, starting from oligonucleotide libraries
via pPEP7 plasmid libraries to S. pneumoniae D39V
libraries; CSP, competence-stimulating peptide. (C)
Workflow of selection assays of D39V libraries and
the identification of the promoter strengths of in-
dividual strains; (–), negative selection; (+), positive
selection; (−/+), sequential selection; C, control; ERY,
erythromycin, high, 5 μg·mL−1; low, 0.05 μg·mL−1;
PCPA, para-chlorophenylalanine, 2 mg·mL−1; SPT,
spectinomycin, 100 μg·mL−1. (D–G) Gene expression
strength (luminescence from luciferase expression)
of P2 promoter variants from 24 randomly selected
colonies per selection condition of the UP library (D),
the CORE library (E), the TATA library (F), and the
PROX library (G); ×102 etc., normalized luminescence
between 1.0 × 102 and 9.9 × 102 RLU·OD−1 (relative
luminescence units per optical density at 595 nm)
(Methods). (H) Sequence and expression strength of
four promoters of the UP library (in comparison to
P2), derived from negative selection (P-B2), sequen-
tial selection (P-C7), and positive selection (P-E9 and
P-F6); transcription start sites are shown in bold, re-
striction sites are shown in dark gray, and sequence
deviations are underlined.






































promoters (sequential selection), or with spectinomycin for weak
promoters (negative selection). After overnight incubation, cells
from 24 individual colonies per selection condition were ana-
lyzed by cultivation in microtiter plates. Luminescence from lu-
ciferase expression served as readout of the promoter strength.
Transformants originating from the control treatment dem-
onstrated a wide range of promoter strengths, as measured by
luminescence (Fig. 2 D–G). In case of the UP, CORE, and
PROX libraries, at least half of the control transformants showed
high levels of luminescence (1.0 × 105 to 9.9 × 106 relative lu-
minescence units per optical density at 595 nm [RLU·OD−1])
(Fig. 2 D, E, and G). In contrast, random sampling of isolates
from the TATA library did not yield promoters with similar
strength compared with the template promoter, which carries the
consensus TATAAT sequence, confirming the importance of the
canonical −35 and −10 sequences for functional promoters
(Fig. 2F). Importantly, promoters of a desired strength (strong,
intermediate, or weak) could be selectively enriched from all four
promoter libraries (Fig. 2 D–G). For example, when counter
selecting with PCPA, only transformants showing low levels of lu-
minescence were recovered, while selection in the presence of
erythromycin led to the recovery of transformants with high gene
expression activity (Fig. 2 D–G). To examine whether the libraries
were diverse in sequence, four promoters of the UP library (one
weak, one intermediate, and two strong ones) were sequenced.
Indeed, all UP element sequences deviated from the P2 template
promoter (Fig. 2H). Interestingly, both the weak and the inter-
mediate promoters contained an additional sequence deviation
within the −10 hexamer, suggesting that random sequence vari-
ations within the UP element did not frequently result in an
impairment of the promoter activity of P2.
TetR- and LacI-Regulated Promoters. The above-mentioned results
showed that our cloning vector and our selection platform could
be successfully applied to identify constitutive promoters of desired
strength. Next, we sought to identify controllable promoters, from
which transcription can be induced by the exogenous addition of
small molecules. To date, there are only few inducible systems
available for S. pneumoniae, showing different drawbacks for specific
applications. These systems are either based on pneumococcal
regulators and they are thus not orthogonal (24, 32–34), or
they are regulated by peptides and thus require complex,
membrane-associated uptake and signaling machineries (35,
36), or they show a limited dynamic range (37). We aimed at
introducing orthogonal transcription factors into S. pneumo-
niae that are regulated by small diffusible molecules, and that
enable a large dynamic range. The most commonly used and
best characterized bacterial regulators are the TetR and LacI
repressors, which bind in the form of dimers to operator sites
(tetO and lacO, respectively) consisting of 19- to 21-bp-long
DNA sequences with dyad symmetry. TetR originates from the
tetracycline-resistance operon encoded in Tn10 of E. coli and
responds to the antibiotic tetracycline (38, 39), while LacI
represses the lac-operon and responds to the sugar allolactose
(40). These compounds interact with their corresponding repressors
and trigger conformational changes that dramatically decrease the
binding affinity for operator sites. Importantly, nontoxic and non-
degradable inducer molecules to these repressors exist: ATc
(anhydrotetracycline) in the case of TetR, and IPTG (isopropyl
β-D-1-thiogalactopyranoside) in the case of LacI.
We codon-optimized tetR and lacI for expression in S. pneumoniae
D39V and integrated them, together with an optimal pneumococcal
ribosome binding site (24), upstream of the multiple cloning site of
pPEP, under control of the previously identified strong constitutive
promoter PF6 (Fig. 2H). The resulting plasmids pPEP8T and
pPEP8L harbor luc and gfp in the BglBrick cloning site for gene
expression analysis (Fig. 3 B and C). Oligonucleotide libraries
used to identify constitutive promoters (Fig. 2) are less helpful
for selecting TetR- and LacI-repressed promoters because the
number of spacer nucleotides that separate operator sites from
critical promoter sequences, such as the −10 hexamer, cannot be
easily randomized using standard oligonucleotide synthesis. In
this case, we took a more directed approach and placed operator
sites in altering positions within the core and the proximal region
of P2, which were found to be tolerant for sequence variations
(Fig. 2 E and G). The sequences of five promoters for TetR (PT)
and five promoters for LacI (PL) are shown in Fig. 3A. PT and
PL promoters were cloned in front of luc and gfp into pPEP8T
and pPEP8L, and plasmids were transformed into S. pneumoniae
D39V. Transformants were grown and analyzed by microtiter
plate reader assay in duplicate, with one well serving as a control
for full promoter repression (no inducer), and one well containing
saturating concentrations of inducer molecules for maximum
induction.
Within the PT promoter series, a single tetO site (tetO1) (41)
was placed either into the core region (PT1-1) or into the
proximal region (PT4-1) of P2, which gave rise to similar results,
with expression values for the induced and the repressed state
within approximately three orders of magnitude (Fig. 3 A and B).
For PT5-3, two operator sites were placed both into the core and
into the proximal region, resulting in a gene expression activity of
3.4 × 106 RLU·OD−1 in the presence of ATc, and 3.6 × 102
RLU·OD−1 in the absence of ATc (indistinguishable from control
cultures without luciferase), and thus giving rise to a dynamic ex-
pression range of approximately four orders of magnitude (Fig. 3B).
We furthermore analyzed −10 sequence variants of PT4-1,
harboring TAAAAT in the case of PT8-2, and TATCAT in the
case of PT8-6 (Fig. 3A). Both the induced and the repressed
expression values of PT8-2 were downshifted one order of
magnitude compared to PT4-1, demonstrating that promoter
leakiness in the repressed state can be reduced by decreasing the
overall expression strength (Fig. 3B). PT8-6 showed even lower
expression in the induced state compared to PT8-2; lumines-
cence of the repressed state, however, did not decrease any
further because the lower detection limit for luciferase expres-
sion was reached (Fig. 3B). The expression curve of an induction
series of PT8-2, compared to PT4-1, was found to be similar but
downshifted. Interestingly, PT5-3, harboring two tetO sites,
showed a more hypersensitive dose–response relationship for
ATc induction compared to PT4-1 and PT8-2 that harbor only
one tetO site (Fig. 3D).
For the PL promoter series, the positioning of lacO sites
(lacOsym) (42) within the core region (PL1-2) resulted in weak
expression in the induced state, presumably because of the in-
troduction of a −35 sequence variation (Fig. 3 A and C). In
contrast, positioning in the proximal region (PL14-2) resulted in
a strong expression of 7.1 × 106 RLU·OD−1 when adding IPTG.
Luminescence of repressed cultures was not completely sup-
pressed and gave rise to a measurement of 8.1 × 103 RLU·OD−1
(Fig. 3C). LacI repressors are known to be able to tetramerize by
binding two operator sites that are in proximity to one another
(43). The spacing between these two lacO sites is critical because
repressor molecules need to face each other in order to loop
DNA and form stable LacI tetramer–DNA complexes (44).
Placing an additional lacO site (lacO1) (45) at the distal region
(72.5 bp upstream of the first operator site, as measured from
center to center of the lacO sites) did not lead to an improved
repression, and luminescence levels were similar compared to
PL14-2, which harbors only one lacO site. However, when
shifting the second operator 4 bp further upstream, we could
observe an eightfold reduction of luminescence in the repressed
state compared to PL14-2; unfortunately, this also led to a
twofold reduction in the induced state (Fig. 3C). Serendipi-
tously, another clone with a double lacO site was isolated, called
PL8-2, which differs from PL8-1 by two spontaneous insertions,
one additional nucleotide in the distal operator site and one






























additional nucleotide in the proximal region (Fig. 3A). PL8-2
showed the largest induction range of the PL promoter series,
spanning four orders of magnitude, with an expression strength
of 9.5 × 106 RLU·OD−1 in the induced state and 1.2 × 103
RLU·OD−1 in the repressed state (Fig. 3C). PL8-2 also showed
the strongest hypersensitive response toward IPTG induction
(Fig. 3E).
To examine controllable gene expression at the single-cell
level, strains D-PEP8T5-3 and D-PEP8L8-2, harboring pro-
moters with the highest dynamic range (promoters PT5-3,
hereafter called Ptet, and PL8-2, hereafter called Plac) were
grown at varying concentrations of ATc and IPTG, and GFP
expression was visualized by fluorescence microscopy. A clear
dose–response relationship was found within the induction series
of each strain (Fig. 3 F and G). Together, these results suggest
that Ptet and Plac display a dynamic induction range of four
orders of magnitude, making them the best controllable pro-
moters currently available for S. pneumoniae. Indeed, our labo-
ratory has successfully used Plac in several studies to accurately
express transcription of various genes in S. pneumoniae (46, 47).
Recently, another group also established a LacI-based IPTG-
inducible system for use in S. pneumoniae (48), further demon-
strating the demand for such small-molecule orthogonal induc-
ible systems in this organism.
Inducible Systems Performing Logical Operations. To build gene-
regulatory networks of higher complexity, individual parts need
to work in a robust manner, independent of their genomic lo-
cation. To test whether the here-described repressor systems can
be expressed from an ectopic locus, and thus distal to the pro-
moters which they regulate, we integrated the TetR and LacI
repressors at the nonessential prsA locus (49) (Methods)
(Fig. 4B). Genes of interest under the control of Ptet or Plac
were integrated at the amiF (CEP) locus via the pPEP9 series of
plasmids, which differs from pPEP8T and pPEP8L by omitting
the repressors. Gene expression activity of Ptet (strain D-T-
PEP9Ptet) and Plac (strain D-L-PEP9lac) was similar compared
to strains harboring the repressor cassette at the amiF locus
(strains D-PEP8T5-3 and D-PEP8L8-2, respectively) (Figs. 3 D
and E and 4 C and D).
Fig. 3. ATc- and IPTG-inducible promoters. (A) Sequence of TetR-repressed PT promoters and LacI-repressed PL promoters, based on the constitutive pro-
moter P2, with TetR operator sequences in light blue and LacI operator sequences in magenta; transcription start sites are shown in bold, restriction sites are
shown in dark gray (not shown for most LacI promoters because of space limitations), and sequence deviations (originating from degenerate oligos or from
spontaneous mutations during cloning) are underlined. (B and C) Luminescence from luciferase expression, driven by PT promoters (B) and PL promoters (C),
without induction and with maximum induction, integrated at the amiF locus together with the strong constitutive promoter PF6 driving regulator ex-
pression; ATc, anhydrotetracycline; IPTG, isopropyl β-D-1-thiogalactopyranoside; error bars, see Methods. (D and E) Induction series of selected PT promoters
with ATc (D) and of selected PL promoters with IPTG (E), measured by normalized luminescence; error bars and fit curves, see Methods. (F and G) Overlay of
phase contrast and fluorescence microscopy of pneumococcal cells expressing GFP driven by PT5-3 (Ptet) in dependency of ATc induction (F) and driven by PL8-
2 (Plac) in dependency of IPTG induction (G). (Scale bar, 2 μm.)






































More complex programming of gene expression, as for ex-
ample Boolean logic gates, requires the integration of multiple
signals into one single response (50, 51). We wondered whether a
P2-based promoter could be used to create a logic AND gate for
external induction, requiring both ATc and IPTG. To test this,
the synthetic promoter Ptela was constructed that contains a tetO
site within the core region and a lacO site within the proximal
region (Fig. 4A). Strain D-LT-PEP9Ptela, which drives luc from
Ptela and expresses both LacI and TetR from the prsA locus, was
found to require both ATc and IPTG to highly express luciferase
(Fig. 4 C–E). LacI repression on its own (with ATc but without
IPTG) was not enough to completely shut down Ptela activity
(Fig. 4E). However, the absence of ATc, and thus TetR re-
pression alone, was enough to decrease luminescence below the
detection limit even in the presence of 1 mM IPTG (Fig. 4E).
The results above show that both TetR and LacI can be
functional within the same cell. Next, we wondered whether the
ATc- and IPTG-inducible systems could be used in parallel and
independent from one another. We therefore generated the
double-inducible integration plasmid pPEPdi, with promoter
Ptet positioned in the BglBrick cloning site, and promoter Plac in
an upstream inverse position within the terminator-insulated
BglBrick transfer site (24). Note that Plac, in the context of
pPEPdi, harbors different flanking restriction sites, with NheI
upstream and BclI downstream of the promoter sequence
(Fig. 4A). Two variants of pPEPdi were tested in strains
expressing both LacI and TetR at the prsA locus: D-LT-PEPdiT
driving luc and gfp from Ptet, and D-LT-PEPdiL driving luc and
gfp from Plac (Fig. 4B). Ptet induction in this context was found
to closely match the values obtained with PT5-3, without any
observable interference from the additionally present LacI
(Fig. 4C). Plac expression, in contrast, deviated from the corre-
sponding PL8-2 pattern, with a twofold decreased maximum
luminescence in the presence of high concentrations of IPTG
(Fig. 4D). Weaker luminescence signals from Plac in the double-
inducible system, compared to PL8-2, could originate from a
decreased promoter activity caused by the inverse reading ori-
entation (into the direction of DNA replication) or from the
sequence deviation in the proximal region (BclI instead of the
BglII site). Alternatively, the translation efficiency might be
decreased because of the alteration within the 5′-UTR. Never-
theless, the double-inducible system showed to work without
interference between the two regulators.
With the TetR- and LacI-regulated systems in place, we
wondered whether we could construct a system where the ex-
pression of one repressor is controlled by the activity of the other
repressor, giving rise to IMPLY gates (Fig. 4 F and G). To do so,
we controlled the amount of LacI via Ptet induction (strain D-T-
PEPdiLL; scheme in Fig. 4F), and the amount of TetR via Plac
induction (strain D-L-PEPdiTT; scheme in Fig. 4G). Indeed,
both strains D-T-PEPdiLL and D-L-PEPdiTT were found to act
as effective IMPLY gates. Interestingly, while Ptet showed the
same maximum expression in the absence of TetR as in the
presence of fully de-repressed TetR, in the case of Plac, lumi-
nescence was twofold higher in the absence of LacI compared to
fully de-repressed LacI. This observation confirms the findings of
a previous study with E. coli showing that de-repressed LacI does
not completely lose its affinity for lacO sites (52).
Construction and Characterization of Single-Copy Toggle Switches.
Heterogeneous expression of virulence factors within bacterial
populations, such as the polysaccharide capsule in S. pneumo-
niae, may contribute importantly to pathogenicity (53–55). To be
able to improve our understanding of such expression patterns,
we aimed at engineering synthetic regulatory networks that are
bistable, and that can thus give rise to bimodal population dis-
tributions (12). A classic example of such a network is the so-
called toggle switch, in which two transcription regulators repress
the expression of each other (14). The prsA site was used to
integrate a genetic toggle switch into the pneumococcal genome
(Fig. 5A). Note that there are only few descriptions of a single-
copy chromosomally integrated synthetic toggle switch, in con-
trast to toggle switches on replicating plasmids (56).
Toggle switch 1 (TS1) harbors the promoters Ptet (identical to
PT5-3; with restriction sites XbaI upstream and AseI down-
stream) driving lacI, and Plac (identical to PL8-2; with restriction
sites XbaI upstream and BglII downstream) driving tetR
(Fig. 5A). Reporter genes were integrated into the S. pneumo-
niaeD39V genome at the amiF locus. Based on pPEPdi, pPEP10
was created, with the erythromycin resistance marker erm, luc,
and gfp driven from Ptet, and the kanamycin resistance marker
aphA driven from Plac (Fig. 5A). Separating the toggle switch
from reporter genes increased the robustness of the system, and
it furthermore allowed for straightforward replacement of re-
porter genes. Toggle switch strains were triggered, either with
IPTG or with ATc, by plating and overnight incubation, followed
by 8 h cultivation in liquid medium in the presence of inducer (to
allow for the establishment of stable expression equilibria;
Fig. 5B). Next, induced cultures were replated and regrown for
8 h in liquid medium without inducer to allow for the settlement
of gene expression at stable states, and for switching events to
occur (Fig. 5B).
When assuming that Ptet and Plac expression in the toggle
switch context results in identical patterns as found for the
double-inducible system, then the TetR-regulated expression of
Ptet and the LacI-regulated expression of Plac can be combined
into one plot, displaying the gene expression regulation of the
toggle switch (SI Appendix, Fig. S2). Intersections of the two
expression curves represent steady states in which gene expres-
sion activity of the two promoters and the concentration of the
two repressors are in equilibrium. Three steady states emerge,
with the outer two representing stable states, and the middle one
representing the threshold of the bistable switch. The proximity
of this threshold to one of the stable states indicates that naturally
occurring fluctuations within cells might be sufficient to trigger
switching events. Fluctuations can originate, among others, from
unequal distributions of repressor molecules after cell division or
from prolonged promoter accessibility after spontaneous repressor
dissociation.
In the case of the promoter pair Ptet and Plac (TS1), the
predicted positioning of the steady states indicates that cells
containing high levels of TetR and low levels of LacI are more
likely to remain in their current state than cells containing low
levels of TetR and high levels of LacI (SI Appendix, Fig. S2). We
therefore created two additional toggle switches, TS2 and TS3,
by modifying the −10 sequence of Plac (TS2, Plac2 −10 sequence
TAAAAT; TS3, Plac3 −10 sequence TATCAT) with the goal of
finding bistability patterns with similar spacing between the
threshold and the two stable states. Deviations of the canoni-
cal −10 sequence were previously shown to downshift the ex-
pression curve of an induction series (10-fold for TAAAAT, and
presumably 20-fold for TATCAT; Fig. 3 B and D).
The three resulting strains, D-TS1-PEP10, D-TS2-PEP10, and
D-TS3-PEP10 (Fig. 5B and SI Appendix, Fig. S2), were analyzed
for resistance toward: 1) spectinomycin (resistance marker of
PEP), indicating the total number of viable cells; 2) kanamycin,
indicating the number of cells with low levels of LacI (and pre-
sumably high levels of TetR; from here on, T-state); 3) eryth-
romycin, indicating the number of cells with low levels of TetR
(and presumably high levels of LacI; from here on, L-state); 4)
kanamycin and erythromycin, serving as a control (Fig. 5D and SI
Appendix, Fig. S3 A and B). Cells of colonies that emerged in the
presence of both kanamycin and erythromycin likely contained
mutations. Cell populations were furthermore analyzed by flow
cytometry, whereat high GFP-fluorescence indicated cells in
the L-state, and low fluorescence indicated cells in the T-state






























(Fig. 5D and SI Appendix, Fig. S2). Additionally, cells of both
induced cultures and of cultures after replating without inducer
were analyzed by fluorescence microscopy (Fig. 5D and SI Ap-
pendix, Fig. S2).
Cells harboring TS1 that were previously treated with IPTG
were all found in the corresponding T-state (SI Appendix, Fig.
S2). In contrast, only ∼50% of the TS1 cells from ATc pre-
treatment were found in the L-state, and the remaining half had
switched to the T-state (SI Appendix, Fig. S2). These findings
matched the prediction made based on the plot in SI Appendix,
Fig. S2. In the case of TS2, cells from IPTG-pretreated cultures
were also all found in the T-state (SI Appendix, Fig. S2). For ATc
pretreatment, the number of TS2 cells that had switched from
the L-state to the T-state was found to be ∼0.5%, and thus two
orders of magnitude lower compared with TS1 (SI Appendix, Fig.
S2). Transitions from the L-state to the T-state were found to
occur even less frequently in TS3 cultures, with only ∼0.01% of
cells showing kanamycin resistance (Fig. 5D). However, in TS3
strains, also cells of cultures that were pretreated with IPTG
were found to be able to switch, in this case from the T-state to
the L-state, with a frequency of ∼0.1% of cells within the ob-
served time period (Fig. 5D).
Remarkably, an additional prediction that was made based on
the plot in Fig. 5C could be confirmed. When decreasing the
promoter strength of Plac within the toggle switch, one would
expect a lower TetR concentration in the L-state, which in turn
should result in cells expressing higher levels of GFP. Indeed,
flow cytometry measurements showed that the peak of fluores-
cence intensity shifted in the direction of the x-coordinate, from
TS1 over TS2 to TS3, with the mode of TS1 cells found at output
level #362, for TS2 cells at #388, and for TS3 cells at #398
(arbitrary units; Methods) (Fig. 5D and SI Appendix, Fig. S2).
After the characterization of TS3, we attempted to identify
intermediate induction levels that would allow TS3 populations
to bifurcate after inducer removal. Two strains harboring TS3
were tested in parallel, one expressing luciferase from Plac
(D-TS3-PEPdiLK) and the other one expressing luciferase from
Ptet (D-TS3-PEPdiT) (SI Appendix, Fig. S2). Growth cultures
were adapted to different inducer concentration ranges, followed
by inducer removal and cultivation without inducer (SI Appendix,
Fig. 4. Construction of inverters, amplifiers, and a logic AND gate. (A) Sequence and restriction sites of the TetR+LacI double-repressed promoter Ptela, and
Ptet (renamed PT5-3) and Plac (renamed PL8-2) in the context of the double-inducible system PEPdi, with TetR operator sequences in light blue and LacI
operator sequences in magenta; transcription start sites are shown in bold, and restriction sites are indicated in dark gray. (B) Schematic representation of
gene expression regulation constructs, with the regulators expressed from the prsA locus and the genes of interest expressed from the amiF locus; genR,
gentamicin resistance marker; sptR, spectinomycin resistance marker; gray circles indicate transcription terminators. (C and D) Induction series of TetR-
regulated promoters with ATc (C) and of LacI-regulated promoters with IPTG (D) of the strains shown in B, measured by luminescence; for Ptela induction
series with ATc, 1,000 μM IPTG was added to de-repress LacI; for Ptela induction series with IPTG, 100 ng·mL−1 ATc was added to de-repress TetR; error bars
and fit curves seeMethods. (E–G) Boolean logical operators, expressing luciferase in the absence of inducer and during induction with ATc (100 ng·mL−1), IPTG
(1,000 μM), and ATc + IPTG, from Ptela (E), Plac (F), and Ptet (G).






































Fig. S3). Two out of six tested conditions resulted in strong
luminescence of both Plac and Ptet after inducer removal,
indicating that the population indeed bifurcated, with significant
fractions of cells developing toward both stable states (SI Appendix,
Fig. S3).
To examine the dynamics of a population bifurcation, we in-
duced cells of strain D-TS3-diLK with different concentrations
of IPTG and ATc and analyzed single cells by fluorescence mi-
croscopy (SI Appendix, Fig. S3). Induced cells of starting cultures
(time point 0 h) showed both GFP and mKate2 fluorescence, in
dependency of the initial induction level. Within 2 h after in-
ducer removal, the fluorescence of individual cells could be de-
tected either in the GFP- or in the mKate2-fluorescence channel,
but none of the analyzed cells resulted in signals above back-
ground levels in both channels (SI Appendix, Fig. S3). After 4 h,
the stable states were consolidated. In agreement with the toggle
switch architecture, at higher initial IPTG concentrations, a
larger fraction of cells developed the L-state (only expressing
mKate2) and fewer cells developed the T-state (only expressing
GFP). Finally, we followed population bifurcations of TS3 by
time-lapse microscopy (Fig. 5F). Starting from single D-TS3-
diLK cells, microcolonies of phenotypically mixed progeny
emerged, with individual cells fluorescing either green or red
(Fig. 5F and Movie S1).
Synthetic Gene-Regulatory Networks Can Control Pneumococcal
Virulence In Vivo. To test whether the tools generated here can
be applied to study pneumococcal virulence and pathogenicity,
we focused on rewiring gene expression of the capsule locus (cps)
as capsule production is indispensable for pneumococcal viru-
lence (3). We recently demonstrated that doxycycline can be
used to induce TetR-controlled dCas9 in vivo (57). Therefore,
we focused on using TetR as a basis for the control of the capsule
operon. The S. pneumoniae D39V serotype 2 capsule operon
consists of 17 genes driven by a primary promoter positioned
upstream of the first gene, cps2A, and by a weaker secondary
promoter after the sixth gene (10) (Fig. 6A). We first generated
an ATc/doxycycline-inducible cps strain (YES-cps) by replacing
the native primary cps promoter by Ptet. At the same locus but in
a different orientation, we cloned tetR. To alleviate growth stress
caused by doxycycline’s antimicrobial activity, we also introduced
the tetM resistance marker (Fig. 6A). This ATc/doxycycline-in-
ducible construct is called a YES-gate as it will only express cps
in presence of inducer. Next, we applied the previously described
IMPLY gate and replaced the native cps promoter for the Plac
promoter (Fig. 6A). In this strain, cps is thus only expressed in
the absence of inducer and is repressed in the presence of ATc/
doxycycline (IMPLY-cps). To examine capsule production, we
performed immunofluorescence using serotype 2-specific anti-
bodies (Methods and SI Appendix, Fig. S4A). As shown in Fig. 6B,
pneumococcal cells harboring the YES-cps construct produce
high amounts of capsule in the presence of ATc but only low
levels of capsule in the absence of ATc. They also displayed
premature autolysis in absence of ATc, characteristic of a Δcps
mutant (SI Appendix, Fig. S4B). Conversely, in case of the IMPLY-cps
network, low levels of capsule are observed in the presence of ATc,
as well as early autolysis, while high levels of capsule are produced in
the absence of ATc (Fig. 6C and SI Appendix, Fig. S4B).
To test whether these networks can also be controlled in vivo,
we utilized a so-called superinfection model in which mice are
first infected with 50 plaque-forming units (PFU) of influenza A
virus (IAV) followed 7 d later by intranasal (i.n.) infection of 5 ×
104 CFU of S. pneumoniae (Fig. 6D). This superinfection model
is highly relevant to human infections and S. pneumoniae causes
a robust and reproducible pneumonia in the context of influenza
virus respiratory infection (4, 58). To confirm that cps is im-
portant for virulence in this superinfection model, we first
compared the bacterial load in the lung at 24 h postinfection
(hpi) of mice infected with wild-type D39V or a Δcps mutant. As
shown in Fig. 6E, a low bacterial load was observed in the Δcps
mutant compared to wild type (D39V vs. Δcps; P < 0.001,
Mann–Whitney test). Next, we compared the YES-cps and
IMPLY-cps strains in which mice were fed ad libitum with chow
containing 200 mg/kg doxycycline or control chow for 4 d prior to
i.n. pneumococcal infection (Fig. 6D). Note that this dose of
doxycycline does not alter S. pneumoniae burden in blood or
lungs at 24 hpi and 48 hpi (57). As shown in Fig. 6E, the bacterial
loads in the lungs were much higher in doxycycline-fed mice
compared to control chow-fed mice in case of the YES-cps strain
(YES-cps −Dox vs. YES-cps +Dox; P < 0.001), and lower in
mice infected with the IMPLY-cps strain on control chow com-
pared to doxycycline-fed mice (IMPLY-cps −Dox vs. IMPLY-cps
+Dox; P < 0.05). Together, these results show that our TetR-
based synthetic gene-regulatory networks can be used to control
gene expression in vivo.
Discussion
Here, we created and characterized a selection tool for gene
expression regulation in S. pneumoniae by combining the coun-
terselection marker pheS, the selection marker erm, the population
reporter luc, and the single-cell reporter gfp. This selection platform
was used to generate and analyze libraries of constitutive pneu-
mococcal promoters. Operator sequences for the E. coli-derived
repressors TetR and LacI were integrated into core and proximal
promoter regions that showed tolerance for sequence variations,
and a set of inducible promoters was created and characterized.
Based on the two promoters with the largest dynamic range, Ptet
and Plac, spanning approximately four orders of magnitude, regu-
latory networks of higher complexity were assembled and analyzed
including the successful construction of logic gates (Fig. 4) and
toggle switches (Fig. 5). This emphasizes the modularity of pro-
karyotic promoters and provides a framework for the construction
of semisynthetic promoters in S. pneumoniae, which respond to
their original regulators, and additionally to orthogonal regulators,
such as TetR or LacI.
S. pneumoniae represents an interesting candidate for syn-
thetic biology applications. The straightforward uptake of exog-
enous DNA and stable integration into the genome via natural
competence allows for stable copy numbers and tightly con-
trolled gene expression of artificial regulatory networks. Fur-
thermore, pneumococci have a small genome of ∼2 million base
pairs, and thus reduced genetic redundancy. More than 25,000
pneumococcal genome sequences are available, ranging from
strains used for fundamental research, isolates from healthy
carriers, and clinical isolates from patients with invasive diseases.
The field of clinical and fundamental research of pneumococci
could in turn also profit from synthetic biology research with the
organism, by receiving new tools that might help answering re-
search questions that are difficult to address with conventional
methods. It is therefore of importance to adapt tools developed
for model organisms, as a proof of principle, to bacteria of in-
terest, such as human pathogens.
To this effect, the approaches applied here allowed us to build
complex gene-regulatory networks, such as genetic toggle switches,
into the genome of pneumococcus to accurately control gene ex-
pression. In a next step, we showed that these networks can be used
to drive capsule production allowing for in vivo investigations of the
contribution of gene expression regulation on the pathogenicity of
the pneumococcus. Future work should investigate how finely such
TetR-based networks can be tuned in vivo. In any case, the ap-
proaches used here may serve as an example for synthetic biology
projects in unrelated organisms.
Methods
Strains and Growth Conditions. S. pneumoniae D39V or strain VL3508 (D39V
Δcps::ery, laboratory collection) was used throughout (10), and E. coli






























MC1061 was used for subcloning. E. coli competent cells were obtained by
CaCl2 treatment (59); transformations were carried out via heat shock at
42 °C. S. pneumoniae transformations were carried out with cultures at OD
(600 nm) 0.1 in the presence of 1 ng·mL−1 CSP (competence-stimulating
peptide) (60). Promoters and genes of interest were assembled in pPEP
(24) via BglBrick cloning (61) followed by integration into the D39V genome
at the amiF locus. Integration constructs inside the prsA locus (49) (replacing
base pairs 29751 to 30077) were assembled via Gibson assembly (62) and
directly transformed to S. pneumoniae (63). Construction of YES-cps and
IMPLY-cps is described in SI Appendix. Pneumococcal cells were cultivated in
C + Y medium (64) (pH 6.8) supplemented with 0.5 mg·mL−1 D-luciferin for
luminescence measurements, at a temperature of 37 °C. Precultures for all
experiments were obtained by a standardized protocol, in which previously
exponentially growing cells from −80 °C stocks were diluted to OD 0.005 and
grown until OD 0.1 in a volume of 2 mL of medium in tubes that allow for
direct (in-tube) OD measurement. For selection assays, and to determine the
number of colony-forming units, cells were plated inside Columbia agar
supplemented with 3% (vol/vol) sheep blood and incubated overnight at
37 °C. For counterselection assays with PCPA, equal volumes of two freshly
prepared stock solutions, 20 mg·mL−1 in 1 M NaOH and 20 mg·mL−1 in 1 M
HCl, were mixed in C + Y medium or Columbia agar; control cultures with the
highest resulting NaCl concentrations (without PCPA) were found to not
impact pneumococcal growth behavior. Key plasmids will be made available
via Addgene.
Microtiter Plate Reader Assays. Costar 96-well plates (white, clear bottom)
with a total assay volume of 300 μL per well were inoculated to the desig-
nated starting OD value. Microtiter plate reader experiments were per-
formed using a TECAN infinite pro 200 (Tecan Group) by measuring every
10 min with the following protocol: 5 s shaking, OD (595 nm) measurement
with 25 flashes, luminescence (RLU, relative luminescence units, a.u.) mea-
surement with an integration time of 1 s. Average and SEM of normalized
luminescence (RLU·OD−1) were determined between OD 0.01 and OD 0.02,
based on three measurements of duplicates (and thus six data points). Fit
curves for induction series were based on the four-parameter Hill equation:
f(x) = s + β
(KAx )
n + 1,
with s, minimum expression; β, maximum expression; n, Hill coefficient; and
KA, dissociation constant. The following parameters were found (s; β; n; KA):
Fig. 3D: D-PEP8PT4-1 (4,000; 6.3 × 106; 2.1; 6.0), D-PEP8PT8-2 (360; 7.1 × 105;
2.1; 9.3), D-PEP8PT5-3 (360; 3.4 × 106; 3.3; 11); Fig. 3E: D-PEP8PL14-2 (8,100;
7.1 × 106; 1.8; 54), D-PEP8PL8-1 (1,000; 2.9 × 106; 1.9; 140), D-PEP8PL8-2 (1,200;
9.5 × 106; 2.2; 54); Fig. 4 C and D: D-L-PEP9Plac (1,100; 9.0 × 106; 2.2; 63), D-LT-
PEP9PLtela (1,800; 9.0 × 105; 1.6; 62), D-LT-PEPdiL (870; 4.4 × 106; 2.0; 65);
Fig. 5. Identification of toggle switches. (A) Sche-
matic representation of strain D-TS-PEP10 containing
a transcriptional toggle switch at the prsA locus (TS)
and genes of interest at the amiF locus (PEP10); genR,
gentamicin resistance marker; sptR, spectinomy-
cin resistance marker; aphA, kanamycin resistance
marker; erm, erythromycin resistance marker; gray
circles indicate transcription terminators. (B) Work-
flow of D-TS-PEP10 induction and the subsequent
identification of switching events; ABX, antibiotics;
ERY, erythromycin, 1 μg·mL−1; GEN, gentamicin,
20 μg·mL−1; IPTG, 1,000 μM; ATc, 100 ng·mL−1; KAN +
ERY, kanamycin, 500 μg·mL−1, and erythromycin,
1 μg·mL−1; KAN, kanamycin, 500 μg·mL−1; SPT, spec-
tinomycin, 100 μg·mL−1. (C) Overlay of the fit curves
corresponding to TetR-dependent Ptet expression
(light blue) and LacI-dependent Plac3 expression
(magenta) to indicate stable states (circles) and the
threshold (circle with asterisk) of the toggle switch.
(D) Number of resistant cells that were able to form
colonies (CFUs mL−1, colony forming units per 1 mL
of cell culture at OD600 0.1) from cultures derived
after plating without inducer (average and SEM of
experimental duplicates are shown), and flow
cytometry analysis of these cultures measuring the
fluorescence intensity of 104 cells (gray lines, dis-
playing output levels #0 to #600 of a 10-bit channel,
arbitrary units; Methods); underneath, an overlay of
phase contrast and fluorescence microscopy of
D-TS3-PEP10 cells are shown, with cells originating
from induced cultures on the left and cells origi-
nating from cultures after plating without inducer
shown on the right side of the arrow (scale bar,
2 μm); D-TS3-PEP10, Plac3 (-10 sequence): TATCAT.
(E) Schematic representation of strain D-TS3-PEP-
diLK, harboring toggle switch 3 (TS3) at the prsA
locus and reporter genes at the amiF locus; mK2,
mKate2; gray circles indicate transcription termina-
tors. (F) Still images (phase contrast and fluorescence
microscopy) of a time-lapse experiment of D-TS3-
PEPdiLK cells previously treated with 100 ng·mL−1
ATc + 50 μM IPTG growing on a semisolid surface
without inducer. (Scale bar, 5 μm.)






































Fig. 4D: D-T-PEP9Ptet (340; 3.4 × 106; 3.3; 15), D-LT-PEP9Ptela (350; 8.4 × 105;
2.1; 9.7), D-LT-PEPdiT (370; 3.4 × 106; 3.3; 13); SI Appendix, Fig. S2A: D-L-PEP-
diTT (380; 3.3 × 106; −2.9; 7,000); SI Appendix, Fig. S2B: D-T-PEPdiLL (870; 1.0 ×
107; −1.9; 22,000).
Microscopy. A Nikon Ti-E microscope equipped with a CoolsnapHQ2 camera
and an Intensilight light source were used. Microscopy was carried out by
spotting cells on a 10% polyacrylamide slide containing PBS, inside a Gene
Frame (Thermo Fisher Scientific) that was sealed with the cover glass to
guarantee stable conditions. Images of fluorescing cells were taken with the
following protocol and filter settings: 300-ms exposure for phase contrast,
1-s exposure for fluorescence at 440- to 490-nm excitation via a dichroic
mirror of 495 nm and an emission filter at 500 to 550 nm. For the induction
series shown in Fig. 3 E and F, D-PEP8T5-3 and D-PEP8L8-2 cells were precultivated
according to standard protocol (to OD 0.1), followed by a 100-fold dilution and
regrowth to OD 0.1 in the presence of ATc and IPTG, respectively.
For time-lapse microscopy, strain D-TS3-PEPdiLK was diluted into 2 mL of
CY medium until a starting OD (600 nm) 0.005 and grown at 37 °C until OD
(600 nm) 0.3. Cells were then rediluted into fresh CY medium supplemented
with 200 μM IPTG and 100 ng·μL ATc until OD (600 nm) 0.005 and grown for
8 h while keeping the OD (600 nm) < 0.05. After 8 h, 2 mL of cells at OD (600 nm)
0.05 were harvested by centrifugation 7 min at 3,000 × g and washed twice with
1 mL of fresh prewarmed CY medium. Cell pellet was resuspended into 1 mL of
fresh CY medium and spotted onto a 1.2% agarose-CY pad placed into a Gene
Frame and closed with a cover glass (65). The slide was mounted onto a Leica
DMi8 microscope equipped with a sCMOS DFC9000 (Leica) camera with a 100×/
1.40 oil-immersion objective and an environmental chamber at 30 °C, allowing
cell growth. After ∼10 min, and every 20 min for 5 h, phase contrast signal was
Fig. 6. In vivo control of capsule production mod-
ulates pneumococcal virulence. (A) Schematic over-
view of the capsule operon of S. pneumoniae strain
D39V, the cps mutant, and the YES-cps and IMPLY-
cps strains. The primary promoter is shown in gray
upstream of cps2A, and a weaker secondary tran-
scription start site is indicated by an arrow (upstream
of cps2F). (B and C) Immunofluorescence of the
capsular polysaccharides (CPS) of the YES-cps strain
(B) in which the native primary promoter of the
operon responsible for capsule production (cps) was
replaced by Ptet or the IMPLY-cps strain (C) where
cps is driven by Plac, repressed by LacI, itself pro-
duced in presence of tetracycline as it is under TetR
control. Epifluorescence signal overlaid with phase
contrast image indicate the presence of high or low
amount of capsule when cps is expressed (B) or re-
pressed (C) upon addition of 100 ng·mL anhydrote-
tracycline (ATc). (Scale bar, 3 μm.) (D) Schematic
representation of the murine superinfection model.
IAV, influenza A virus; i.n., intranasal infection.
Without capsule (red dots), most S. pneumoniae cells
will be eliminated by the host immune system, while
they can survive and replicate in presence of capsule
(thick red layer). Bacteria are collected from the
lungs 24 hpi, and viable cells quantified (CFU). (E–G)
Number of bacteria that were able to form colonies
from the lungs of mice fed on control chow and in-
fected with D39V or Δcps (E), YES-cps (F), or IMPLY-
cps (G) or fed on doxycycline-containing chow (Dox)
and infected with YES-cps (F), or IMPLY-cps (G). Each
dot represents a single mouse. Mann–Whitney test
was used for analysis. *P < 0.05; ***P < 0.001.






























imaged using transmission light and 100-ms exposure time, and both fluorescent
signals were acquired using 17% of excitation light and 400-ms exposure
time with a SOLA Light Engine (lumencor). GFP signal was obtained using
a GFP filter cube with 470/40-nm excitation filter (Chroma; #ET470/40×)
and 520/40-nm emission filter (Chroma; #ET520/40 m). mKate2 signal was
obtained using a mCherry filter cube with excitation and emission filters
at 560/40- and 590-nm long pass, respectively (Chroma; #49017). Images
were processed using LAS X (Leica), and signal was deconvolved with
Huygens (SVI) software using only one iteration. Time-lapse movie was
edited with Fiji software (66).
Flow Cytometry. The fluorescence intensity of 104 cells was measured by a BD
FACS Canto Flow Cytometer (BD Biosciences) at medium flow, with the de-
tectors for forward scatter and side scatter set to 200 and 500 V, respectively.
A gate was defined based on forward- and side-scatter measurements to
exclude the recording of particles that deviated from normal S. pneumoniae
cells. The detector for fluorescence was set to 750 V. Results shown in Fig. 5D
and SI Appendix, Fig. S2 represent smoothed data (running average) of
output levels #0 to #600 of a 10-bit channel (total number of 1,024 output
levels), whereat measurements from output levels #0 to #300 were fitted to
a normal distribution for visual clarity; the detection of weakly fluorescing
cells in our flow cytometer suffered from machine biases, showing periodi-
cally repeating stretches of empty reads and culmination at output level #0.
Capsule Immunofluorescence. For visualization of the polysaccharide capsule,
S. pneumoniaewas grown in CYmedium supplemented with or without 100 ng·μL
ATc until OD (600 nm) 0.3, then rediluted into fresh CY medium and grown
until OD (600 nm) 0.1. Cells were then harvested by centrifugation, washed,
and resuspended in fresh prewarmed CY medium. The 1:1,000 pneumococcus
type 2 serum (SSI Diagnostica) was added, and cells were incubated for 5 min
on ice. After two washes with fresh CY medium, 1:1,000 of secondary Alexa
Fluor 555-conjugated goat anti-rabbit antibody (Invitrogen; A27039) was
added, and cells were incubated in ice for 5 min. The stained cells were then
washed twice with fresh CY medium and once with ice-cold PBS. The pellet
was then resuspended in PBS for imaging using epifluorescence.
Mouse Experiments. Superinfection experiments complied with national, in-
stitutional, and European regulations and ethical guidelines, were approved
by our Institutional Animal Care and Use Committee (animal facility agree-
ment C59-350009; Institut Pasteur de Lille; protocol APAFIS#5164), and were
conducted by qualified, accredited personnel. Male C57BL/6JRj mice (6 to
8 wk old) (Janvier Laboratories) were maintained in individually ventilated
cages and handled in a vertical laminar flow biosafety cabinet (Class II Bio-
hazard; Tecniplast). Prior to infections by i.n. route, each mouse was anes-
thetized by i.p. injection of 1.25 mg of ketamine plus 0.25 mg of xylazine in
250 μL of PBS. On day 1, flu infection was performed i.n. with 50 PFU of the
pathogenic, murine-adapted H3N2 influenza A virus strain Scotland/20/74 in
30 μL of PBS (67, 68). Mice were fed starting on day 3 postflu on control diet
or diet supplemented with doxycycline (200 mg/kg; Ssniff Spezialdia ̈ten
GmbH). On day 7, S. pneumoniae infection is done i.n. with frozen working
stocks at 5 ×104 CFU of the YES-cps and IMPLY-cps strains in 30 μL of PBS as
described previously (67). Infections with D39V and Δcps strains that were fed
on control diet was used to standardize the results. At 24-h postpneumococcal
infection, mice were killed by i.p. injection using 5.47 mg of sodium pento-
barbital in 100 μL of PBS and lungs were sampled in 1 mL of PBS. Serial dilutions
of lung homogenates were plated to evaluate CFU counts.
Data Availability. All study data are included in the article and SI Appendix.
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